Explore News
-
Breakthrough in Atropisomer Synthesis with 90% Yield
A new biocatalytic deracemization method enables efficient synthesis of enantioenriched atropisomers
-
Why FDA Scientists Are Warning Against Peptide Drugs
Federal health scientists urge caution on peptide drugs as FDA advisory panel undergoes changes
-
Why the US-UK drug deal is a matter of life and death
New analysis reveals the devastating impact of the US-UK trade deal on the NHS
-
Why Cystic Fibrosis Patients Are Turning to Generics
Generic version of Trikafta offers new hope for cystic fibrosis patients worldwide
-
Why RFK Jr. is Backing Un-tested Peptides
RFK Jr.’s FDA panel appointments spark controversy over peptide drugs
-
AstraZeneca’s New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar
AstraZeneca’s elecoglipron pill achieves significant weight loss and blood sugar reduction
-
Why Wegovy’s New Pill Form Matters for UK Health
Novo Nordisk introduces daily tablet for weight loss
-
Why Opioids Often Don’t Work for Pain
Landmark study raises concerns about overprescription and side effects
-
Muscle Growth Drug Reduces Lean Tissue Loss by 20%
New research suggests a monoclonal antibody can help retain lean body mass during weight loss…









